249 related articles for article (PubMed ID: 25931810)
1. Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.
Zhang L; Xu X; Yang R; Chen J; Wang S; Yang J; Xiang X; He Z; Zhao Y; Dong Z; Zhang D
Drug Des Devel Ther; 2015; 9():2139-48. PubMed ID: 25931810
[TBL] [Abstract][Full Text] [Related]
2. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
[TBL] [Abstract][Full Text] [Related]
4. Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway.
Qin T; Wu Y; Liu T; Wu L
BMC Complement Med Ther; 2021 Jan; 21(1):12. PubMed ID: 33407391
[TBL] [Abstract][Full Text] [Related]
5. Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs.
Chen XW; Duan W; Zhou SF
Drug Des Devel Ther; 2015; 9():4869-71. PubMed ID: 26379422
[No Abstract] [Full Text] [Related]
6. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
7. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
Ponnusamy M; Zhou X; Yan Y; Tang J; Tolbert E; Zhao TC; Gong R; Zhuang S
J Pharmacol Exp Ther; 2014 Aug; 350(2):243-56. PubMed ID: 24833701
[TBL] [Abstract][Full Text] [Related]
8. Loss of poly(ADP-ribose) polymerase 1 attenuates renal fibrosis and inflammation during unilateral ureteral obstruction.
Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F450-9. PubMed ID: 21613422
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c.
Yu Y; Wang Y; Niu Y; Fu L; Chin YE; Yu C
Am J Physiol Renal Physiol; 2015 Oct; 309(7):F595-603. PubMed ID: 26155847
[TBL] [Abstract][Full Text] [Related]
11. FTY720 ameliorates renal fibrosis by simultaneously affecting leucocyte recruitment and TGF-β signalling in fibroblasts.
Tian T; Zhang J; Zhu X; Wen S; Shi D; Zhou H
Clin Exp Immunol; 2017 Oct; 190(1):68-78. PubMed ID: 28658504
[TBL] [Abstract][Full Text] [Related]
12. Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling.
Li Y; Guo F; Huang R; Ma L; Fu P
Int Immunopharmacol; 2021 Feb; 91():107279. PubMed ID: 33340783
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.
Meng LQ; Tang JW; Wang Y; Zhao JR; Shang MY; Zhang M; Liu SY; Qu L; Cai SQ; Li XM
Br J Pharmacol; 2011 Apr; 162(8):1805-18. PubMed ID: 21232035
[TBL] [Abstract][Full Text] [Related]
14. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.
Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S
J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732
[TBL] [Abstract][Full Text] [Related]
15. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
Du Y; Zhang W; Liu S; Feng X; Gao F; Liu Q
Biochem Biophys Res Commun; 2018 Sep; 503(1):177-180. PubMed ID: 29885836
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney.
Ni J; Shen Y; Wang Z; Shao DC; Liu J; Fu LJ; Kong YL; Zhou L; Xue H; Huang Y; Zhang W; Yu C; Lu LM
Acta Pharmacol Sin; 2014 Aug; 35(8):1045-54. PubMed ID: 24976155
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Elp2 prevents renal fibrosis and inflammation induced by unilateral ureter obstruction (UUO) via inactivating Stat3-regulated TGF-β1 and NF-κB pathways.
Lu S; Fan HW; Li K; Fan XD
Biochem Biophys Res Commun; 2018 Jun; 501(2):400-407. PubMed ID: 29723529
[TBL] [Abstract][Full Text] [Related]
18. Heat Shock Protein 72 Antagonizes STAT3 Signaling to Inhibit Fibroblast Accumulation in Renal Fibrogenesis.
Zhou Y; Cao S; Li H; Peng X; Wang Y; Fan J; Wang Y; Zhuang S; Yu X; Mao H
Am J Pathol; 2016 Apr; 186(4):816-28. PubMed ID: 26851345
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
[TBL] [Abstract][Full Text] [Related]
20. STAT3 Inhibition Partly Abolishes IL-33-Induced Bone Marrow-Derived Monocyte Phenotypic Transition into Fibroblast Precursor and Alleviates Experimental Renal Interstitial Fibrosis.
Zhu F; Bai X; Hong Q; Cui S; Wang X; Xiao F; Li J; Zhang L; Dong Z; Wang Y; Cai G; Chen X
J Immunol; 2019 Nov; 203(10):2644-2654. PubMed ID: 31591147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
